Showing results (51-60 of 120) with videos related to
Sort By:
Pageof 12
International Journal of Molecular Sciences|April 5, 2016
The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and ChallengesRolf Teschke, Axel EickhoffFrontiers in Pharmacology|August 17, 2019
Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and FutureGaby Danan, Rolf TeschkeAnnals of Hepatology|October 21, 2009
Severe hepatotoxicity by Indian Ayurvedic herbal products: a structured causality assessmentRolf Teschke, Ruediger BahreInternational Journal of Molecular Sciences|January 12, 2018
Molecular Research on Drug Induced Liver InjuryRolf Teschke, Gaby DananDrug Safety|August 18, 2012
Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US PharmacopeiaRolf Teschke, Johannes SchulzeInternational Journal of Molecular Sciences|May 11, 2024
Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis UpdateRolf Teschke, Axel EickhoffInternational Journal of Molecular Sciences|April 3, 2021
Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and ControversiesRolf Teschke, Gaby DananDrug Safety|March 5, 2018
Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?Gaby Danan, Rolf TeschkeJournal of Clinical and Translational Hepatology|August 27, 2025
Acute Liver Failure with Determinate rather than Indeterminate Etiology Facilitates Therapy and May Avoid Liver Transplantation: A Critical AnalysisRolf Teschke, Axel EickhoffDrug Safety|April 20, 2016
Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver DiseaseRolf Teschke, Gaby DananPageof 12